Evaluation of Polyflex Stenting in Esophageal Cancer Patients
Launched by UNIVERSITY OF LOUISVILLE · Aug 1, 2008
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age and older
- • Willing and able to provide informed consent
- • Willing to comply with follow-up requirements
- • Biopsy-confirmed esophageal cancer (adenocarcinoma or squamous cell carcinoma) in mid or distal esophagus (clinical stage 3 or less)
- • Indicated for chemotherapy and/or radiation therapy
- • Ability to dilate stricture to 15mm diameter at extent of disease evaluation
- • Placement of at least 18 x 23mm diameter and 120mm length PolyFlex stent
- Exclusion Criteria:
- • Patients contraindicated for endoscopy
- • Patients with prior esophageal stent placements
- • Advance stage of disease, greater than T3 tumor or M1 disease
About University Of Louisville
The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louisville, Kentucky, United States
Patients applied
Trial Officials
Robert Martin, MD
Principal Investigator
University of Louisville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials